Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study

Toto, Sermin; Grohmann, Renate; Bleich, Stefan; Frieling, Helge; Maier, Hannah B.; Greil, Waldemar; Cordes, Joachim; Schmidt-Kraepelin, Christian; Kasper, Siegfried; Stuebner, Susanne; Degner, Detlef; Druschky, Katrin; Zindler, Tristan und Neyazi, Alexandra (2019): Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study. In: International Journal of Neuropsychopharmacology, Bd. 22, Nr. 9: S. 560-573

Abstract

Background: Psychotropic drugs are the cornerstone of schizophrenia treatment, often requiring lifelong treatment. Data on pharmacotherapy in inpatient settings are lacking. Methods: Prescription data of schizophrenic inpatients within the time period 2000-2015 were obtained from the database of the Drug Safety Program in Psychiatry (AMSP). Data were collected at 2 index dates per year;the prescription patterns and changes over time were analyzed. Results: Among 30 908 inpatients (mean age 41.6 years, 57.8% males), the drug classes administered most often were antipsychotics (94.8%), tranquilizers (32%), antidepressants (16.5%), antiparkinsonians (16%), anticonvulsants (14.1%), hypnotics (8.1%), and lithium (2.1%). The use of second-generation antipsychotics significantly increased from 62.8% in 2000 to 88.9% in 2015 (P<.001), whereas the prescription of first-generation antipsychotics decreased from 46.6% in 2000 to 24.7% in 2015 (P<.001). The administration of long-acting injectable antipsychotics decreased from 15.2% in 2000 to 11.7% in 2015 (P=.006). Clopazine was the most often used antipsychotic, having been used for 21.3% of all patients. Polypharmacy rates (>= 5 drugs) increased from 19% in 2000 to 26.5% in 2015. Psychiatric polypharmacy (>= 3 psychotropic drugs) was present in 44.7% of patients. Conclusions: Combinations of antipsychotics and augmentation therapies with other drug classes are frequently prescribed for schizophrenic patients. Though treatment resistance and unsatisfactory functional outcomes reflect clinical necessity, further prospective studies are needed on real-world prescription patterns in schizophrenia to evaluate the efficacy and safety of this common practice.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 1461-1457
• Sprache: Englisch